Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)

BACKGROUND: The renin‐angiotensin‐aldosterone system (RAAS), when chronically activated, is harmful and RAAS‐suppressive drugs are beneficial in the treatment of congestive heart failure (CHF). Mineralocorticoid receptor antagonists are widely used in the treatment of CHF in people. HYPOTHESIS/OBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffman, Melissa, Guillot, Emilie, Blondel, Thomas, Garelli‐Paar, Catherine, Feng, Shuo, Heartsill, Susanne, Atkins, Clarke E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295662/
https://www.ncbi.nlm.nih.gov/pubmed/34028078
http://dx.doi.org/10.1111/jvim.16155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295662/
https://www.ncbi.nlm.nih.gov/pubmed/34028078
http://dx.doi.org/10.1111/jvim.16155

Ejemplares similares